Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Efficacy of AVP-923 for Pseudobulbar Affect in Multiple Sclerosis Patients
This study has been completed.
Study NCT00050232   Information provided by Avanir Pharmaceuticals
First Received: December 2, 2002   Last Updated: August 4, 2009   History of Changes

No Study Results Posted for this Study
About Study Results Reporting
  Study Status: This study has been completed.
  Estimated Study Completion Date: December 2004
  Estimated Primary Completion Date: No date given